SEC Form 4 · accession 0001437749-17-009958
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Tobin
Director
Period of report
May 22, 2017
Accepted (ET)
May 24, 2017 · 10:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2017 | M | 5,000 | $5.63 | A | 41,309 | D | |
| Common Stock | May 22, 2017 | F | 2,132 | $13.20 | D | 39,177 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (Right to Buy) | $5.63 | May 22, 2017 | M | 5,000 | D | May 26, 2010 | May 26, 2017 | Common Stock | 5,000 | 10,000 | D |